These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22260094)

  • 1. A molecular carrier to transport and deliver cisplatin into endometrial cancer cells.
    Borrelli A; Schiattarella A; Musella A; Mancini R; Capasso C; De Luca V; Carginale V; Sanseverino M; Tornesello AL; Gori E; Pica A; Di Santi A; Basile F; Iacobellis F; Colacurci N; Cobellis L; Mancini A
    Chem Biol Drug Des; 2012 Jul; 80(1):9-16. PubMed ID: 22260094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The leader peptide of a human rec. MnSOD as molecular carrier which delivers high amounts of Cisplatin into tumor cells inducing a fast apoptosis in vitro.
    Borrelli A; Schiattarella A; Mancini R; Morelli F; Capasso C; De Luca V; Gori E; Mancini A
    Int J Cancer; 2011 Jan; 128(2):453-9. PubMed ID: 20309937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new hexapeptide from the leader peptide of rMnSOD enters cells through the oestrogen receptor to deliver therapeutic molecules.
    Borrelli A; Schiattarella A; Mancini R; Pica A; Pollio ML; Ruggiero MG; Bonelli P; De Luca V; Tuccillo FM; Capasso C; Gori E; Sanseverino M; Carpentieri A; Birolo L; Pucci P; Rommelaere J; Mancini A
    Sci Rep; 2016 Jan; 6():18691. PubMed ID: 26725847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells.
    Borrelli A; Schiattarella A; Mancini R; Morrica B; Cerciello V; Mormile M; d'Alesio V; Bottalico L; Morelli F; D'Armiento M; D'Armiento FP; Mancini A
    Free Radic Biol Med; 2009 Jan; 46(1):110-6. PubMed ID: 18996183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R
    Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent.
    Mancini A; Borrelli A; Schiattarella A; Aloj L; Aurilio M; Morelli F; Pica A; Occhiello A; Lorizio R; Mancini R; Sica A; Mazzarella L; Sica F; Grieco P; Novellino E; Pagnozzi D; Pucci P; Rommelaere J
    Int J Cancer; 2008 Dec; 123(11):2684-95. PubMed ID: 18798256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation-Dependent Effects of a New Recombinant Manganese Superoxide Dismutase on Human SK-N-BE Neuron-Like Cells.
    Crestini A; Vona R; Lo Giudice M; Sbriccoli M; Piscopo P; Borrelli A; Rivabene R; Ricceri L; Mancini A; Confaloni A
    Neurochem Res; 2019 Feb; 44(2):400-411. PubMed ID: 30471001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
    Bae-Jump VL; Zhou C; Boggess JF; Gehrig PA
    Cancer; 2009 Sep; 115(17):3887-96. PubMed ID: 19484784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel and cisplatin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay.
    Engblom P; Rantanen V; Kulmala J; Grènman S
    Anticancer Res; 1996; 16(4A):1743-7. PubMed ID: 8712694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
    Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rMnSOD on survival signaling in pediatric high risk T-cell acute lymphoblastic leukaemia.
    Pica A; Di Santi A; D'angelo V; Iannotta A; Ramaglia M; Di Martino M; Pollio ML; Schiattarella A; Borrelli A; Mancini A; Indolfi P; Casale F
    J Cell Physiol; 2015 May; 230(5):1086-93. PubMed ID: 25294747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
    Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
    Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):424-31. PubMed ID: 15496615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal.
    Adjei AA; Budihardjo II; Rowinsky EK; Kottke TJ; Svingen PA; Buckwalter CA; Grochow LB; Donehower RC; Kaufmann SH
    Clin Cancer Res; 1997 May; 3(5):761-70. PubMed ID: 9815747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
    Engel JB; Honig A; Schönhals T; Weidler C; Häusler S; Krockenberger M; Grunewald TG; Dombrowski Y; Rieger L; Dietl J; Wischhusen J
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):64-9. PubMed ID: 18687514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants specifically inhibit cisplatin cytotoxicity of human malignant glioma cells.
    Roller A; Weller M
    Anticancer Res; 1998; 18(6A):4493-7. PubMed ID: 9891515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
    Kendrick JE; Straughn JM; Oliver PG; Wang W; Nan L; Grizzle WE; Stockard CR; Alvarez RD; Buchsbaum DJ
    Gynecol Oncol; 2008 Mar; 108(3):591-7. PubMed ID: 18177927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer.
    Yoshida H; Sumi T; Zhi X; Yasui T; Honda K; Ishiko O
    Anticancer Res; 2011 Apr; 31(4):1271-7. PubMed ID: 21508375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer cell lines are sensitive to paclitaxel.
    Rantanen V; Grénman S; Kulmala J; Grénman R
    Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.